Ooma (OOMA) Competitors $14.15 +0.14 (+0.99%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends OOMA vs. EVH, LZ, TASK, SEZL, FVRR, NVEE, OLO, PGRU, PSFE, and CTOSShould you be buying Ooma stock or one of its competitors? The main competitors of Ooma include Evolent Health (EVH), LegalZoom.com (LZ), TaskUs (TASK), Sezzle (SEZL), Fiverr International (FVRR), NV5 Global (NVEE), OLO (OLO), PropertyGuru Group (PGRU), Paysafe (PSFE), and Custom Truck One Source (CTOS). These companies are all part of the "business services" industry. Ooma vs. Evolent Health LegalZoom.com TaskUs Sezzle Fiverr International NV5 Global OLO PropertyGuru Group Paysafe Custom Truck One Source Evolent Health (NYSE:EVH) and Ooma (NYSE:OOMA) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation. Is EVH or OOMA more profitable? Evolent Health has a net margin of -2.93% compared to Ooma's net margin of -3.83%. Evolent Health's return on equity of 6.30% beat Ooma's return on equity.Company Net Margins Return on Equity Return on Assets Evolent Health-2.93% 6.30% 2.57% Ooma -3.83%-2.51%-1.32% Do analysts recommend EVH or OOMA? Evolent Health currently has a consensus price target of $21.92, suggesting a potential upside of 118.84%. Ooma has a consensus price target of $16.60, suggesting a potential upside of 17.33%. Given Evolent Health's stronger consensus rating and higher possible upside, research analysts clearly believe Evolent Health is more favorable than Ooma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Evolent Health 0 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 3.00Ooma 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Which has more risk and volatility, EVH or OOMA? Evolent Health has a beta of 1.45, meaning that its share price is 45% more volatile than the S&P 500. Comparatively, Ooma has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500. Does the MarketBeat Community prefer EVH or OOMA? Evolent Health received 204 more outperform votes than Ooma when rated by MarketBeat users. Likewise, 74.57% of users gave Evolent Health an outperform vote while only 69.75% of users gave Ooma an outperform vote. CompanyUnderperformOutperformEvolent HealthOutperform Votes56674.57% Underperform Votes19325.43% OomaOutperform Votes36269.75% Underperform Votes15730.25% Does the media refer more to EVH or OOMA? In the previous week, Evolent Health had 21 more articles in the media than Ooma. MarketBeat recorded 22 mentions for Evolent Health and 1 mentions for Ooma. Ooma's average media sentiment score of 0.88 beat Evolent Health's score of 0.13 indicating that Ooma is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evolent Health 3 Very Positive mention(s) 5 Positive mention(s) 4 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Neutral Ooma 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders have more ownership in EVH or OOMA? 80.4% of Ooma shares are held by institutional investors. 1.6% of Evolent Health shares are held by company insiders. Comparatively, 9.8% of Ooma shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has stronger valuation & earnings, EVH or OOMA? Ooma has lower revenue, but higher earnings than Evolent Health. Ooma is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEvolent Health$1.96B0.59-$113.04M-$0.91-11.01Ooma$236.74M1.61-$830K-$0.37-38.24 SummaryEvolent Health beats Ooma on 13 of the 19 factors compared between the two stocks. Get Ooma News Delivered to You Automatically Sign up to receive the latest news and ratings for OOMA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OOMA vs. The Competition Export to ExcelMetricOomaData processing & preparation IndustryComputer SectorNYSE ExchangeMarket Cap$382.00M$4.38B$27.12B$19.94BDividend YieldN/A3.00%2.78%3.71%P/E Ratio-38.2433.94236.9041.41Price / Sales1.617.243,720.9916.25Price / Cash31.3030.5534.3219.84Price / Book4.676.128.395.76Net Income-$830,000.00$44.77M$669.90M$993.25M7 Day Performance3.95%3.97%3.66%3.12%1 Month Performance-1.54%3.11%4.89%4.75%1 Year Performance33.85%19.24%24.37%18.83% Ooma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OOMAOoma1.7233 of 5 stars$14.15+1.0%$16.60+17.3%+33.9%$382.00M$236.74M-38.241,221Positive NewsEVHEvolent Health2.8188 of 5 stars$12.37-1.4%$22.83+84.6%-66.8%$1.44B$2.46B-13.595,100LZLegalZoom.com3.0056 of 5 stars$7.88+4.8%$8.81+11.8%-24.3%$1.36B$678.84M60.621,220TASKTaskUs1.3294 of 5 stars$15.05-1.1%$17.00+13.0%+26.4%$1.34B$955.01M25.5148,200SEZLSezzle4.0905 of 5 stars$221.94-2.9%$366.00+64.9%+510.4%$1.24B$221.81M23.61540FVRRFiverr International1.6711 of 5 stars$31.91+0.3%$32.30+1.2%+30.5%$1.23B$379.32M122.74790NVEENV5 Global3.2874 of 5 stars$18.27-3.2%$28.75+57.4%-31.0%$1.19B$914.19M32.483,640Positive NewsOLOOLO2.1054 of 5 stars$7.22-0.4%$8.67+20.0%+55.6%$1.18B$271.87M-72.19710PGRUPropertyGuru Group0.1169 of 5 stars$6.70flat$7.00+4.5%N/A$1.10B$157.82M-74.441,410PSFEPaysafe1.9666 of 5 stars$17.38+0.9%$19.40+11.6%+26.6%$1.06B$1.70B-45.743,200News CoveragePositive NewsCTOSCustom Truck One Source1.9663 of 5 stars$4.52+0.4%$5.63+24.4%-25.5%$1.06B$1.80B-28.252,580Short Interest ↓News Coverage Related Companies and Tools Related Companies Evolent Health Alternatives LegalZoom.com Alternatives TaskUs Alternatives Sezzle Alternatives Fiverr International Alternatives NV5 Global Alternatives OLO Alternatives PropertyGuru Group Alternatives Paysafe Alternatives Custom Truck One Source Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:OOMA) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ooma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ooma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.